Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies.
Booth C, Ribeil JA, Audat F, Dal-Cortivo L, Veys PA, Thrasher AJ, Davies EG, Lefrère F, Fischer A, Cavazzana-Calvo M, Gaspar HB. Booth C, et al. Among authors: audat f. Br J Haematol. 2006 Nov;135(4):533-7. doi: 10.1111/j.1365-2141.2006.06333.x. Epub 2006 Oct 10. Br J Haematol. 2006. PMID: 17054675 Free article.
Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.
Lefrère F, Zohar S, Beaudier S, Audat F, Ribeil JA, Ghez D, Varet B, Cavazzana-Calvo M, Dal Cortivo L, Letestu R, McIntyre E, Brouzes C. Lefrère F, et al. Among authors: audat f. Transfusion. 2007 Oct;47(10):1851-7. doi: 10.1111/j.1537-2995.2007.01407.x. Transfusion. 2007. PMID: 17880611
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients.
Lefrère F, Zohar S, Ghez D, Delarue R, Audat F, Suarez F, Hermine O, Damaj G, Maillard N, Ribeil JA, Azagury M, Misbahi R, Jondeau K, Cavazzana-Calvo M, Dal Cortivo L, Varet B. Lefrère F, et al. Among authors: audat f. Bone Marrow Transplant. 2006 Apr;37(8):725-9. doi: 10.1038/sj.bmt.1705308. Bone Marrow Transplant. 2006. PMID: 16518433
A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Lefrère F, Zohar S, Bresson JL, Chevret S, Mogenet A, Audat F, Durand-Zaleski I, Ghez D, Dal Cortivo L, Piesvaux P, Cavazzana-Calvo M, Varet B. Lefrère F, et al. Among authors: audat f. Haematologica. 2006 Apr;91(4):550-3. Haematologica. 2006. PMID: 16585020 Clinical Trial.
High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose.
Lefrère F, Delarue R, Somme D, Levy V, Damaj G, Tu A, Porcher R, Audat F, Boulat C, Cavazzana-Calvo M, Buzyn A, Belanger C, Maillard N, Hermine O, Varet B. Lefrère F, et al. Among authors: audat f. Transfusion. 2002 Apr;42(4):443-50. doi: 10.1046/j.1525-1438.2002.00060.x. Transfusion. 2002. PMID: 12076291
32 results